Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use

Guidance for Industry and Food and Drug Administration Staff for Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use, CBER, Biologics, December 2017

via Whats New Vaccines Blood Biologics RSS Feed http://bit.ly/2Hy4vgS